Meeting
2011 Gastrointestinal Cancers Symposium
The PARSC trial: A prospective study for the assessment of recurrence risk in stage II colon cancer (CC) patients using ColoPrint.
Authors
Ramon Salazar
Instituto Catala d'Oncologia, L'Hospitalet Servicio de Oncologia
Ramon Salazar , John Marshall , Jacobus Van Der Hoeven , Bengt Glimelius , Richard Bender , Josep Tabernero
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Clinical Trial Registration Number
NCT00903565
Citation
J Clin Oncol 29: 2011 (suppl 4; abstr 602)
Abstract #
602
Poster Bd #
A247
Abstract Disclosures
Similar Posters
Poster
2012 ASCO Annual Meeting
The PARSC trial, a prospective study for the assessment of recurrence risk in stage II colon cancer patients using ColoPrint.
First Author: Ramon Salazar
Poster
2012 Gastrointestinal Cancers Symposium
The PARSC trial, a prospective study for the assessment of recurrence risk in stage II colon cancer (CC) patients using ColoPrint.
First Author: Ramon Salazar
Poster
2014 ASCO Annual Meeting
Comparison of ColoPrint risk classification with clinical risk in the prospective PARSC trial.
First Author: Ramon Salazar
Poster
2014 Gastrointestinal Cancers Symposium
Comparison of ColoPrint risk classification with clinical risk in the prospective PARSC trial.
First Author: Ramon Salazar